Seer (SEER) Other Non-Current Liabilities (2020 - 2026)
Seer (SEER) recorded quarterly Other Non-Current Liabilities of $26000.0 in Q1 2026, up 225.0% quarter-over-quarter from $8000.0 in Q4 2025, and down 16.13% on a YoY basis from $31000.0 in Q1 2025.
Seer (SEER) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Seer's Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $26000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 16.13% year-over-year to $26000.0; the TTM figure through Mar 2026 stood at $26000.0 (down 16.13% YoY), while the FY2025 annual figure was $8000.0, down 83.33% from the prior year.
- Other Non-Current Liabilities was $26000.0 for Q1 2026 at Seer, up from $8000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $360000.0 in Q1 2023 to a low of $8000.0 in Q4 2025.
- Historically, Other Non-Current Liabilities has averaged $152764.7 across 5 years, with a median of $157000.0 in 2023.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities climbed 5.57% in 2023, then sank 84.38% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $320000.0 in 2022, then sank by 44.06% to $179000.0 in 2023, then plunged by 73.18% to $48000.0 in 2024, then sank by 83.33% to $8000.0 in 2025, then surged by 225.0% to $26000.0 in 2026.
- The last three Other Non-Current Liabilities figures came in at $26000.0 (Q1 2026), $8000.0 (Q4 2025), and $10000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 173,000.00 |
| Dec 31, 2023 | 179,000.00 |
| Sep 30, 2023 | 157,000.00 |
| Jun 30, 2023 | 174,000.00 |
| Mar 31, 2023 | 360,000.00 |
| Dec 31, 2022 | 320,000.00 |
| Sep 30, 2022 | 319,000.00 |
| Jun 30, 2022 | 323,000.00 |
| Mar 31, 2022 | 341,000.00 |
| Dec 31, 2021 | 341,000.00 |
| Sep 30, 2021 | 402,000.00 |
| Jun 30, 2021 | 402,000.00 |